(2023)
Clinical Implication of Concurrent Amplification of MET and FGFR2 in Metastatic Gastric Cancer.
BIOMEDICINES.
11,
12
(2023)
PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
JOURNAL OF PATHOLOGY.
260,
4
(2023)
TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors.
CANCER MEDICINE.
12,
11
(2023)
Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers.
CANCER MEDICINE.
12,
7
(2023)
Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2? in gallbladder cancer.
Journal of Pathology and Translational Medicine.
57,
2
(2023)
A standardized pathology report for gastric cancer: 2nd edition.
Journal of Pathology and Translational Medicine.
57,
1
(2023)
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer.
Oncology Research.
31,
6
(2023)
Five-gene signature for the prediction of response to immune checkpoint inhibitors in patients with gastric and urothelial carcinomas.
PATHOLOGY RESEARCH AND PRACTICE.
241,
(2023)
Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer.
CANCERS.
15,
2
(2022)
MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer.
PATHOLOGY & ONCOLOGY RESEARCH.
28,
(2022)
The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY.
148,
9
(2022)
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer.
Journal for ImmunoTherapy of Cancer.
10,
7
(2022)
Comparative analysis of microsatellite instability by next-generation sequencing, MSI PCR and MMR immunohistochemistry in 1942 solid cancers.
PATHOLOGY RESEARCH AND PRACTICE.
233,
(2022)
Expression of CD274 mRNA Measured by qRT-PCR Correlates With PD-L1 Immunohistochemistry in Gastric and Urothelial Carcinoma.
FRONTIERS IN ONCOLOGY.
12,
(2022)
Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer.
CANCER DISCOVERY.
12,
4
(2022)
Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing.
JOURNAL OF ONCOLOGY.
2022,
(2022)
Direct comparison of the next-generation sequencing and iTERT PCR methods for the diagnosis of TERT hotspot mutations in advanced solid cancers.
BMC MEDICAL GENOMICS.
15,
1
(2022)
Two Gastric Cancers with Uncommon ALK Fusion Diagnosed with Comprehensive Panel Sequencing and Confirmed with Companion Diagnostic Assay.
AJSP: Reviews and Reports.
27,
1
단행본
(2013)
Gastric Carcinoma: Morphologic Classifications and Molecular Changes IN GASTRIC CARCINOMANEW INSIGHTS INTO CURRENT MANAGEMENT.
InTech.
공동
(2011)
위암과 위장관 질환.
일조각.
공동
(2007)
대한병리학교과서 제6판.
고문사.
공동
특허/프로그램
소화기암 환자의 면역치료 반응성 예측용 TIRAP 마커 및 이의 용도.
10-2017-0126732.
20190826.
대한민국
소화기암 환자의 면역치료 반응성 예측용 TLR3 마커 및 이의 용도.
10-2017-0126749.
20190826.
대한민국
소화기암 환자의 면역치료 반응성 예측용 TLR7 마커 및 이의 용도.
10-2017-0126743.
20190826.
대한민국
소화기암 환자의 면역치료 반응성 예측용 CISH 마커 및 이의 용도.
10-2017-0126728.
20190823.
대한민국
위암의 예후 예측용 마커 및 이의 용도.
10-2017-0126718.
20190823.
대한민국
MET 저해제에 대한 감수성 예측용 조성물(Composition for Predicting Susceptibility to MET Inhibitor).
10-2016-0103773.
20190530.
대한민국
항암제 저항성 또는 민감성 예측용 조성물.
10-2016-0120762.
20190503.
대한민국
위암 아형의 분류 방법 (Methods for classifying subunits of gastric cancer).
10-2016-0048347.
20181204.
대한민국
학술회의논문
(2019)
Combined positive score measured by pathologists and digital image analyses are not significantly different in predicting responses for immune checkpoint blockade therapy in gastric cancer patients.
31th european pathology congress.
프랑스
(2018)
Bridging Genomics and Phenomics of Gastric Carcinoma.
European Congress of Pathology.
스페인
(2017)
Colorectal Adenocarcinoma with ALK Rearrangement: Clinicopathologic and Molecular Characteristics.
USCAP.
미국
(2017)
Hepatoid Carcinomas of the Gastrointestinal Tract: A Reappraisal of Morphological and Immunohistochemical Features.
USCAP.
미국
(2017)
Ideal Number of Biopsy Tumor Fragments for Predicting HER2 Status in Gastric Carcinoma Resection Specimens.
USCAP.
미국
(2017)
Peritumoral lymphoid cuff in gastrointestinal schwannomas is significantly correlated with regional lymph node enlargement: A study of 118 consecutive cases from a single institute.
USCAP.
미국
(2017)
Programmed cell death-ligand 1 expression in microsatellite instability-high gastric carcinomas.
USCAP.
미국
(2017)
RICTOR overexpression/amplification in advanced solid tumors: A correlation study utilizing immunohistochemistry, fluorescence in situ hybridization, and targeted sequencing.
USCAP.
미국
(2016)
Programmed death-ligand 1 (PD-L1) and immune infiltrates are prognostic for better outcome and enriched in the ATM (ataxia telangiectasia mutated)-low segment of gastric cancer.
Annals of Oncology.
영국
(2016)
A nCounter CNV assay to detect HER2 amplification; A correlation study with immunohistochemistry and Fluorescence In Situ Hybridization in a cohort of 220 advanced gastric cancer tissues.
KINGCA Week 2016 & 6th APGCC.
대한민국
(2015)
Genetic heterogeneity in gastric adenocarcinoma.
The 24th KOGO Annual conference 2015.
대한민국
(2015)
Pathology in future medicine.
대한병리학회 봄학술대회.
대한민국
(2015)
위장관 간질성종양의 최신지견.
대한병리학회 소화기병리 연수강좌.
대한민국
(2015)
EBV-associated Gastric Carcinomas Display High Degree Molecular Homogeneity with Focused Deregulation in Immune Response Genes.
Korean International Gastric Week 2015.
대한민국
(2015)
Hereditary Cancer: Stomach cancer.
Seoul International Symposium in Surgical Oncology 2015.
대한민국
(2014)
제19차 대한암학회 학술대회.
대한암학회지.
대한민국
(2014)
대한병리학회 좌장.
대한병리학회 가을학술대회.
대한민국
(2014)
GENETIC ALTERATIONS IN GISTS USING WHOLE EXOME AND TRANSCRIPTOME SEQUENCING.
Annals of Oncology.
스페인
(2014)
Lynch-like syndrome: Characterization and comparison with EPCAM deletion carriers.
Annals of Oncology.
스페인
(2014)
The Oncotest: Multi-Omics Approach for Clinical Cancer Patient Segmentations.
제3차 삼성암병원 심포지엄.
대한민국
